Category : Search result: IPO anchor investors


Meesho IPO Opens: Rs 5,421 Cr Target, 45% GMP

Meesho's IPO opens today, targeting Rs 5,421 crore with a strong 45% grey market premium. Analysts recommend subscribing, citing growth in India's mass-market e-commerce. Read for key details.

Neochem Bio IPO Day 1: Subscription at 0.55x

Neochem Bio Solutions' ₹44.97 crore SME IPO opened for subscription on Dec 2. The issue, priced at ₹93-98/share, saw muted GMP. Discover key dates, allocation, and use of proceeds.

Fujiyama & Capillary IPOs: Investor Guide & GMP

In-depth analysis of Fujiyama Power and Capillary Technologies IPOs. Expert insights on valuation, financials, GMP trends, and which investors should subscribe. Make informed investment decisions.

Tenneco Clean Air IPO Allotment Finalized Today

Tenneco Clean Air IPO share allotment is finalized today. Investors can check their status online. Refunds for unsuccessful applicants begin tomorrow, with shares credited to demat accounts on Tuesday.

Capillary Tech IPO Subscribed 0.29x on Day 1

Capillary Technologies' ₹877.5 crore IPO received a tepid response, subscribed just 0.29 times. Key details on issue size, price band, and how the SaaS firm plans to use the funds.

Pre-IPO investments hit ₹4,300 crore in 2025 amid FOMO

Indian investors rush into pre-IPO placements of companies like Lenskart and Physics Wallah, driving record investments. Discover how FOMO is reshaping IPO strategies and what experts predict for coming months.

Tenneco Clean Air India IPO Raises ₹1,079 Cr

Tenneco Clean Air India's IPO gets a strong start, raising ₹1,079 crore from anchor investors. Discover the details and what it means for the public issue. Stay updated on this developing story.

IPO Market Boom: Key Offerings & Investor Guide

November 2025's IPO market surges with Pine Labs, PhysicsWallah, Emmvee Solar & Tenneco offerings. Expert analysis reveals subscription trends, GMP data & crucial due diligence tips for investors navigating this vibrant landscape.

Mahamaya Lifesciences IPO Opens With Nil GMP

Mahamaya Lifesciences IPO subscription begins. The ₹70.44 crore SME issue sees muted interest with a 2% subscription. Check key details, price band, and financials.

Page 2 of 4